Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

Share Price is delayed by 15 minutes
Get Live Data
820.00    -3.00 (-0.36%)
Bid:
821.00
Ask:
826.00
Spread: 5.00 (0.609%)
Market Cap: £773.07m
POLR Live PriceLast checked at - London Stock Exchange

Intraday Polar Capital Share Chart

AUM Update

17 Oct 2013 07:00

RNS Number : 6606Q
Polar Capital Holdings PLC
17 October 2013
 



17 October 2013

 

Polar Capital Holdings plc

AUM Update

 

Polar Capital Holdings plc ("Polar Capital" or the "Group"), the specialist asset management group, today provides its regular quarterly update of its unaudited statement of its Assets under Management ("AUM").

 

Group AUM (unaudited)

 

As at 30 September 2013 the Group's AUM increased by 58% to $11.4bn from the $7.2bn reported at 31 March 2013. This also represents over a 100% increase in AUM from the $5.3bn reported at 30 September 2012.

 

The table below sets out the movements in the Group's AUM over the six month period:

 

AUM movement

Six months to 30 September 2013

Long only funds

$m

Alternative funds

$m

Total

$m

As at 31 March 2013

$6,371m

$837m

$7,208m

Net subscriptions

$3,239m

$6m

$3,245m

Market movement and performance

$916m

$39m

$955m

Total AUM at 30 September 2013

$10,526m

$882m

$11,408m

 

Comment

 

Polar Capital recorded $3.2bn of net inflows in its first half year with a surprisingly high level of inflows in the historically slower summer second quarter amounting to $1.4bn.

 

In the quarter just commenced the Group's UK team will be leaving Polar Capital. It is not currently expected that a replacement UK team will be recruited. This will result in an outflow (at current market levels) of $293m of AUM in the December quarter.

 

Our overall strategy continues to be based on the presence of ten to twelve world class investment teams. The departure of the UK team will leave ten teams in place leaving further scope to add additional teams should the opportunity arise.

 

Given the renewed uncertainly in markets over recent weeks we would expect the levels of net inflows to be less certain and possibly materially lower in the upcoming quarters notwithstanding the loss of the UK related assets. The Group believes that despite this qualification it remains well positioned to grow both assets and profitability further over the longer term.

 

 

 

Net performance fees (unaudited)

 

The table below sets out the position relating to net performance fees (after the deduction of staff interests) earned and accrued in the first six months of the Group's financial year. The majority of the Group's performance fees crystallise in the second half of the financial year.

 

Performance fees

net of staff allocations

Six months to

30 Sept 12

£m

Year to

31 Mar 13

(year-end)

£m

Six months to

30 Sept 13

£m

Received

£0.0m

£5.5m

£0.0m

Accrued but not yet earned in funds with year ends on or before the financial year end

£4.2m

n/a

£4.5m

Total net performance fees

£4.2m

£5.5m

£4.5m

 

 

For further information please contact:

 

Polar Capital

Tim Woolley (CEO)John Mansell (CFO)

Canaccord Genuity - Nomad and Broker

Simon Bridges (QE)

Martin Green

Cameron Duncan

F T I Consulting

Neil Doyle

Jack Hickey

 

 

+44 (0)20 7227 2700

 

 

+44 (0)20 7523 8000

 

 

+44 (0)20 7269 7132

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAFEKFEFDFFF
Date   Source Headline
13th Aug 20213:57 pmRNSForm 8.3 - Stock Spirits Group PLC
9th Aug 20213:39 pmRNSForm 8.3 - Restore PLC
6th Aug 20214:38 pmRNSForm 8.3 - RESTORE PLC
2nd Aug 20217:00 amRNSDirector/PDMR Shareholding
2nd Aug 20217:00 amRNSBlock listing Interim Review
23rd Jul 20213:44 pmRNSForm 8.3 - RESTORE PLC
20th Jul 20214:15 pmRNSDirector/PDMR Shareholding
19th Jul 20219:54 amRNSDirector/PDMR Shareholding
13th Jul 20211:02 pmRNSDirector/PDMR Shareholding
12th Jul 202112:38 pmRNSDirector/PDMR Shareholding
8th Jul 20212:07 pmRNSAnnual Financial Report
8th Jul 20217:00 amRNSAuM Update
1st Jul 202111:07 amRNSDividend Declaration
1st Jul 202110:26 amRNSDirector Declaration
1st Jul 20217:00 amRNSGroup Audited Results for year ended 31 March 2021
29th Jun 20213:53 pmRNSForm 8.3 - Ultra Electronics Holdings PLC
7th Jun 20217:00 amRNSNotice of Results
1st Jun 20217:00 amRNSTotal Voting Rights
26th May 20215:35 pmRNSDirector/PDMR Shareholding
21st May 20212:21 pmRNSDirector/PDMR Shareholding
20th May 202111:36 amRNSIssue of Equity
20th May 202110:38 amRNSHolding(s) in Company
19th May 20217:00 amRNSForm 8.3 - Immunodiagnostic Systems Holdings PLC
17th May 202112:45 pmRNSDirector/PDMR Shareholding
17th May 20217:00 amRNSDirector/PDMR Shareholding
17th May 20217:00 amRNSIssue of Equity
16th Apr 20217:00 amRNSDirector/PDMR Shareholding
15th Apr 20217:00 amRNSAuM Update
13th Apr 20214:27 pmRNSHolding(s) in Company
1st Apr 202110:44 amRNSDirector/PDMR Shareholding
1st Apr 20217:00 amRNSTotal Voting Rights
25th Mar 20215:45 pmRNSHolding(s) in Company
18th Mar 20214:08 pmRNSHolding(s) in Company
1st Mar 20217:00 amRNSCompletion of Dalton SP LLP Acquisition
26th Feb 20214:33 pmRNSDirector/PDMR Shareholding
26th Feb 20214:32 pmRNSTotal Voting Rights
23rd Feb 20217:00 amRNSIssue of Equity
1st Feb 20215:35 pmRNSIssue of Equity
1st Feb 20217:00 amRNSBlock listing Interim Review
1st Feb 20217:00 amRNSTotal Voting Rights
25th Jan 20217:00 amRNSDirector/PDMR Shareholding
22nd Jan 20217:00 amRNSDirector/PDMR Shareholding
22nd Jan 20217:00 amRNSDirector/PDMR Shareholding
22nd Jan 20217:00 amRNSIssue of Equity
20th Jan 20215:25 pmRNSDirector/PDMR Shareholding
20th Jan 20215:22 pmRNSIssue of Equity
19th Jan 20219:39 amRNSIssue of Equity
18th Jan 20217:00 amRNSDirector/PDMR Shareholding
15th Jan 20217:00 amRNSIssue of Equity
14th Jan 20217:00 amRNSAuM Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.